NinePoint’s NvisionVLE Receives Approval from FDA

by Savitha C Muppala on  April 30, 2013 at 8:12 AM Medical Gadgets
RSS Email Print This Page Comment
Font : A-A+

NinePoint Medical made an announcement following the approval by the FDA for its NvisionVLE Imaging System to be marketed for imaging of esophageal tissue microstructure.
 NinePoint’s NvisionVLE Receives Approval from FDA
NinePoint’s NvisionVLE Receives Approval from FDA

NvisionVLE helps in enabling a 3D image from one scan of the observed organ in record time, which is less than 60 seconds.

Explaining the system, Charles Carignan, M.D., president and chief executive officer of NinePoint Medical, said, "The NvisionVLE Imaging System is the first and only volumetric, optical coherence tomography device cleared by the FDA for endoscopic imaging, and now imaging of esophageal tissue microstructure."

"Expanded FDA 510(k) clearance for imaging of the esophagus represents an important milestone as we progress toward commercializing the NvisionVLE Imaging System this year. We believe that the NvisionVLE Imaging System will allow physicians to see more esophageal tissue for biopsy and treatment procedures, providing them with valuable imaging information," he added.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive